“glomerulonephritis.”的搜索结果，显示 341-350 项，共有 8934 项

1. 妙佑医疗国际 - 研究人员为治疗复杂主动脉瘤而研发新型支架

   ... . VID-20232701. 主页; Researchers Develop New Stents for Complex Aortic Aneurysms - Brightcove. 一份馈赠，无穷力量——今天就来伸出援手！

2. 血液科- 临床试验- 妙佑医疗国际

   This is a peripheral blood Collection Protocol to study the T-cell immune responses of patients with malignancies displaying one of three different patterns ...

3. 血液科- 临床试验- 妙佑医疗国际

   Rochester, Minn. The purpose of this study is to evaluate the immune and hematopoietic compartments in patients with monoclonal B cell lymphocytosis (MBL) and ...

4. 血液科- 临床试验- 妙佑医疗国际

   Ascorbic acid may make cancer cells more sensitive to chemotherapy. Drugs used in chemotherapy, work in different ways to stop the growth of cancer cells, ...

5. 血液科- 临床试验- 妙佑医疗国际

   This phase II trial studies the effect of ascorbic acid and combination chemotherapy in treating patients with lymphoma that has come back (recurrent) or ...

6. 放射科- 临床试验- 妙佑医疗国际

   The purpose of this study is to develop a localizer for use within the 7T MRI to allow for future clinical use in neurosurgical planning. Minnesota Spinal Cord ...

7. 血液科- 临床试验- 妙佑医疗国际

   Rochester, Minn. The purpose of this study is to find out more about the side effects of the CAR-T therapy called IC19/1563 and what dose of IC19/1563 is safe ...

8. 心血管医学- 临床试验- 妙佑医疗国际

   Rochester, Minn. The purpose of this study is to determine the long-term outcome of cardiac resynchronization therapy (CRT) recipients with congestive heart ...

9. 血液科- 临床试验- 妙佑医疗国际

   Rochester, Minn. The purpose of this study is to determine how well tafasitamab, lenalidomide and venetoclax work in treating patients with mantle cell lymphoma ...

10. 血液科- 临床试验- 妙佑医疗国际

    Rochester, Minn. The purpose of this study is to determine if the drug combination of acalabrutinib, durvalumab, and venetoclax will work to treat Richter's ...